Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
High Growth Diagnostics - Technology and Market Analyses
Genomics advances of the 1990s are now resulting in commercial products-both analyte-specific reagents (ASRs) and in vitro diagnostics (IVDs).
Report Overview
D&MD's High-Growth Diagnostics: Technology and Market Analyses of Segments Experiencing Robust Growth in the Various Diagnostics Spaces market analysis report focuses on the market segments within the diagnostics industry that are currently experiencing robust growth. This also analyzes the technologies, markets (both qualitatively and quantitatively), and key companies within this space.
Questions Answered
> Qualitative trends-market drivers, market challenges, bottlenecks, opportunities-in selected high-growth diagnostics segments.
> Quantitative Analysis of Market Segments that together contribute to the growth of the diagnostics space.
> Organisms of importance (have wide market appeal) for infectious disease (ID) diagnostics to be built around.
> Agents of Bio Defense relevance for which diagnostics must be developed-another segment of market opportunity.
Market Opportunities
> Growth opportunity for tools developers to develop reagents, ASRs, technologies, hardware/instrumentation to address the diagnostics growth marketplace.
> Content companies can use this publication to ask where else they can invest.
> Diagnostics companies can use this publication to ask which diagnostics they can license-in, or in guidance to M&A transactions.
Jul-06 Pages 108
Table of Contents
Price
PDF $4,950.00
Printed $4,950.00
CD-ROM $4,950.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.